Histological differences between invasive ductal carcinoma with a large central acellular zone and matrix-producing carcinoma of the breast

Pathology International

Volumn 59, Issue 6, 2009, Pages 390-394

  Sasaki, Yuka ^a,b,g   Tsuda, Hitoshi ^a,c   Ueda, Shigeto ^d   Asakawa, Hideki ^d   Seki, Kunihiko ^c   Murata, Tetsuya ^e   Kuriki, Ken ^f   Tamai, Seiichi ^g   Matsubara, Osamu ^a  

^a Departments of Basic Pathology   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c Departments of Surgery i

^d SUZUKA GENERAL HOSPITAL   (Japan)

^e University of Tokyo   (Japan)

^f NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^g Central Hospital   (Japan)

Author keywords

Breast carcinoma; Carcinoma with a large central acellular zone; Matrix producing carcinoma

Indexed keywords

ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER CELL; CANCER CLASSIFICATION; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPHOCYTIC INFILTRATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; STAINING;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EXTRACELLULAR MATRIX; FEMALE; HUMANS;

EID: 65649117327     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02382.x     Document Type: Article

References (14)

1. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001 98 : 10 869 74. (Pubitemid 32878711)
2. Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003 100 : 8418 23. (Pubitemid 36842560)
3. Banerjee S, Reis-Filho JS, Ashley S et al. Basal-like breast carcinomas: Clinical outcome and response to chemotherapy. J Clin Pathol 2006 59 : 729 35. (Pubitemid 44048783)
4. Rakha EA, Putti TC, Abd El-Rahim DM et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 2006 208 : 495 506. (Pubitemid 43329336)
5. Tsuda H, Takarabe T, Hasegawa T, Murata T, Hirohashi S. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. Hum Pathol 1999 30 : 1134 9. (Pubitemid 29480879)
6. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi S. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 2000 24 : 197 202. (Pubitemid 30078708)
7. Turner NC, Reis-Filho JS. Basal-like breast cancer and the BRCA1 phenotype. Oncogene 2006 25 : 5846 53. (Pubitemid 44453440)
8. Tsuda H, Morita D, Kimura M et al. Correlation of KIT and EGFR overexpression with invasive ductal carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation. Cancer Sci 2005 96 : 48 53. (Pubitemid 40310025)
9. Fulfold LG, Reis-Filho JS, Ryder K et al. Basal-like grade III invasive ductal carcinoma of the breast: Patterns of metastasis and long-term survival. Breast Cancer Res 2006 9 : R4.
10. Reis-Filho JS, Milanezi F, Steele D et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006 49 : 10 21. (Pubitemid 43972916)
11. Tsuda H, Tani Y, Weisenberger J et al. Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features. Cancer Sci 2005 96 : 333 9. (Pubitemid 41007467)
12. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. Matrix-producing carcinoma. Hum Pathol 1989 20 : 628 35. (Pubitemid 19185291)
13. Hama Y, Tsuda H, Sato K, Hiraide H, Mochizuki H, Kusano S. Invasive ductal carcinoma of the breast with a large central acellular zone associated with matrix-producing carcinoma. Tumori 2004 90 : 498 500. (Pubitemid 39556800)
14. Ashida A, Fukutomi T, Ushijima T, Tsuda H, Akashi-Tanaka S, Nanasawa T. Carcinoma with cartilaginous metaplasia of the breast in a patient with germ line BRCA2 mutation. Jpn J Clin Oncol 2000 30 : 30 32.